Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain
R3 Stem Cell · with R3 Medical Research · NCT06361485
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 20+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 1
- Target enrollment
- 100
- US sites recruiting
- 4
- Study start
- March 25, 2024
- Record last updated
- April 11, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a Pilot Study that is an open label, prospective, non-controlled study in which the safety and feasibility of Wharton's Jelly (WJ) allograft will be evaluated in 100 participants suffering with low back pain.
Being studied: Lumbar Injections with 10cc's of Wharton's Jelly Allograft
Conditions: Low Back Pain
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Patient must
- Be over age 20.
- Suffering from chronic lumbar pain
- Body Mass Index (BMI) \<50 Kilograms/m2.
- Pain score of 4 or more on the Numeric Pain Rating Scale (NPRS).
- Female participants must be abstinent, surgically sterilized or postmenopausal.
- Premenopausal females must be on contraceptive measures and do not anticipate pregnancy during the duration of the study.
- Be willing and capable of giving written informed consent to participate in English.
- Be willing and capable of complying with study-related requirements, procedures and visits.
Exclusion Criteria
- Patient must not
- Have taken any pain medication including nonsteroidal anti-inflammatory drugs (NSAIDs) within 2 weeks prior to study injection date.
- Use anticoagulants have a substance abuse history, and fail to agree not to take any lumbar symptom modifying drugs during the course of the study without discussing and reporting the use to the site Clinical investigator and study team.
- Known allergy to penicillin, sulfa or amphotericin medications.
- Have had any lumbar injections (at all) of any drug in lumbar spine in the past 6 months.
- Have had surgery on the lumbar spine within the past 6 months.
- Had a traumatic injury to the lumbar spine with the past 3 months.
- Planned elective surgery during the course of the study.
- A history of organ or hematologic transplantation, rheumatoid arthritis, or other autoimmune disorders.
- Be on immunosuppressive medications.
- Have a diagnosis of carcinoma with the past 5 years.
- Have a lumbar infection or have used antibiotics for lumbar infection within the past 3 months.
- Have participated in any other clinical study or treatment (not just for the lumbar spine, but for any reason) with any investigational product within the past 30 days prior to inclusion of study.
- Female participants who are breast feeding or are pregnant or desire to become pregnant during the course of the study.
- Contraindications to radiographic or MRI imaging.
- Serious neurological, psychological or psychiatric disorders.
- Injury or disability claims under current litigation or pending or approved workers compensation claims.
Recruiting US locations
R3 Anti Aging Scottsdale
Scottsdale, AZ 85262
Site contact: David Greene, MD, PhD, MBA · 480-306-6256 · dgreene@r3medicalresearch.com
R3 Anti Aging Beverly Hills
Beverly Hills, CA 90210
Site contact: Kathleen Francesca, BA · 424-382-1074 · kfrancesca@r3stemcell.com
Scheer Medical Wellness
New York, NY 10036
Site contact: Alexandre Scheer, MD · 646-762-9499 · ascheer911@gmail.com
Dr. Duc (Steve) Le, MD
Cleveland, TX 77327
Site contact: Steve Le, MD · 281-593-1500 · ducstevele@gmail.com
Study contacts (from the official record)
- David L Greene, MD, PhD, MBA · (602) 677-8981 · dgreene@r3medicalresearch.com
- Katherine Minter-Dykhouse, PhD · 4803066256 · kmd@bello.bio
Similar studies in Arizona
All arthritis studies in Arizona →- RecruitingHealthy volunteersPhase 1
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
Eli Lilly and Company
- Location
- Phoenix, AZ + 8 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Merck Sharp & Dohme LLC
- Location
- Chandler, AZ + 35 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Medipost, Inc.
- Location
- Scottsdale, AZ + 33 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)
Doron Therapeutics Inc.
- Location
- Tucson, AZ + 7 other US sites
- Eligibility basics
- Ages 40–80